BioWorld MedTech: Elekta looks to gain MOMENTUM via study of MR/RT for clinical practice

Print Friendly, PDF & Email

Elekta looks to gain MOMENTUM via study of MR/RT for clinical practice

With an eye toward the quick and safe introduction of magnetic resonance radiation therapy (MR/RT), the MR-linac Consortium reported the launch of the MOMENTUM study. The study will focus on building real-world clinical evidence and insights made possible by MR/RT. It also represents the next step in the development of the Elekta Unity MR/RT system. The technology was developed by Elekta in collaboration with the consortium, which, noted John Christodouleas, VP of medical affairs and clinical research at Elekta and a member of MOMENTUM’s management team, includes renowned cancer researchers. “By collaborating on the MOMENTUM study, we expect to accelerate clinical innovations enabled by this breakthrough technology.”

Read Full Story
Next Previous Home